Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Illumina Inc

ILMN
Current price
108.1 USD -0.88 USD (-0.81%)
Last closed 109.07 USD
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 17 220 329 472 USD
Yield for 12 month -46.52 %
1Y
3Y
5Y
10Y
15Y
ILMN
21.11.2021 - 28.11.2021

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California. Address: 5200 Illumina Way, San Diego, CA, United States, 92122

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

146.82 USD

P/E ratio

Dividend Yield

Current Year

+4 504 000 000 USD

Last Year

+4 584 000 000 USD

Current Quarter

+1 076 000 000 USD

Last Quarter

+1 122 000 000 USD

Current Year

+2 744 000 000 USD

Last Year

+2 972 000 000 USD

Current Quarter

+667 000 000 USD

Last Quarter

+675 000 000 USD

Key Figures ILMN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 345 000 000 USD
Operating Margin TTM -5.48 %
PE Ratio
Return On Assets TTM -0.5 %
PEG Ratio 4.296
Return On Equity TTM -20.76 %
Wall Street Target Price 146.82 USD
Revenue TTM 4 493 000 192 USD
Book Value 36.06 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -1 %
Dividend Yield
Gross Profit TTM 3 145 000 000 USD
Earnings per share -8.15 USD
Diluted Eps TTM -8.15 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -96.5 %
Profit Margin -28.71 %

Dividend Analytics ILMN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ILMN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 2:1
Payout Ratio
Last Split Date 23.09.2008
Dividend Date

Stock Valuation ILMN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 129.8701
Enterprise Value Revenue 4.7616
Price Sales TTM 4.493
Enterprise Value EBITDA -35.2733
Price Book MRQ 3.5227

Financials ILMN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ILMN

For 52 weeks

89 USD 202.85 USD
50 Day MA 114.54 USD
Shares Short Prior Month 5 404 263
200 Day MA 126.42 USD
Short Ratio 3.33
Shares Short 5 819 598
Short Percent 3.84 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

446.34 USD Microsoft Corporation -3.37 (-0.75%)
Detailed analytics

ETF funds


S

SLICHA

203.95 CHF UBS SLI A-dis -0.06 (-0.02%)
Detailed analytics

Metals


Gold

2339.94 USD Gold +11.09 (+0.48%)
Detailed analytics